 |
| ADMD Plans Out Next 3 Years Stock Up 16% Today |
|
 Hot Stock to Watch
|
Company: Advanced Medical Isotope Corp. (OTCQB: ADMD)
|
End of Day:
Price: 0.06
Change (%): + 0 (0.00)
Volume: 132,000 |
 |
Advanced Medical Isotope Corporation Announces Three Year Business Strategy Focused on Transitioning From a Development-Stage Company to an Operating Company
Operations to Center on Yttrium-90 Brachytherapy Products Following Anticipated Receipt of FDA Clearance of Y-90 RadioGel(TM) Brachytherapy Device
KENNEWICK, Wash., Dec. 2, 2013 (GLOBE NEWSWIRE) - Advanced Medical Isotope Corporation (“AMIC”) (ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that its Board of Directors has approved a three year business strategy focused on transitioning to full operations in 2014, following the anticipated receipt of FDA clearance for its patented brachytherapy cancer product, Yttrium-90 RadioGel(TM).
The business strategy results from the Company’s success in developing a family of three brachytherapy devices and the Company’s belief that there is: (1) strong market potential for these products in the United States and internationally, (2) the potential for attractive operating margins from the commercialization of such devices, (3) a considerably smaller capital requirement to complete the regulatory process and deploy these devices, as compared to the capital required for most of the other initiatives the Company is developing and (4) a material potential for the Company to receive advances and minimum guarantees from international licensees of these products.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Fresh Start Private Management Inc. (OTCQB: CEYY)
|
End of Day:
Price: 0.089
Change (%): + 0.004 (4.71)
Volume: 41,408 |
 |
Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two main components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers targeted, therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism.
Company Information Sheet |
Other Small Cap News
|
Company: Mantra Venture Group Ltd. (OTCQB: MVTG)
|
Mantra Announces Advancements in Novel Fuel Cell for Energy Storage
BURNABY, BRITISH COLUMBIA--(Marketwired - Dec. 2, 2013) - Mantra Venture Group Ltd.(OTCQB:MVTG) and its subsidiary, Mantra Energy Alternatives Ltd., have announced recent promising experimental advances in developing an innovative platinum- and membrane-free mixed-reactant fuel cell (MRFC) architecturecalled the "Swiss-roll MRFC". The novel Swiss-roll MRFC (licensed exclusively by Mantra Energy Alternatives Ltd.) has been extensively developed in the Department of Chemical and Biological Engineering of the University of British Columbia (UBC) in the Fuel Cells and Applied Electrochemistry Laboratory of Professor Elod Gyenge and Professor Colin Oloman. The development of the Swiss-roll MRFC has been fully supported by UBC, the Clean Energy Research Center and the Natural Science and EngineeringResearch Council of Canada (NSERC) through Discovery and DiscoveryAccelerator programs.
Continue Reading
|
Company: Endexx Corporation (Pink Sheets: EDXC)
|
Endexx Lease Program Gaining Traction
Autospense Pipeline Growing
CAVE CREEK, AZ--(Marketwired - Dec 2, 2013) - Endexx Corporation (OTC Pink: EDXC) is excited to announce that the new sales team is gaining significant traction in the Washington and Colorado markets. In the early stages of rollout of the Autospense platform we are processing lease applications for 3-5 units to be delivered after the first of the year. The new "responsible adult use" and recreational marijuana markets have opened up significant market opportunities for our advanced dispensing systems. The Autospense machine increases business flow rates in retail stores and dispensaries. Average wait times in dispensaries are 20-25 minutes for service. The Autospense system solves this problem, facilitating 4-6 secured transactions in the same amount of time. The unit controls inventories, tracks most requested products in real time, prevents theft and shrinkage, and can perform more efficiently than an individual.
Continue Reading |
Market News
|
By Nick Taborek & Namitha Jagadeesh: Bloomberg
|
U.S. Stocks Fluctuate Amid Retail, Manufacturing Reports
U.S. stocks fluctuated, after the Standard & Poor’s 500 Index rose for a third month, as investors assessed reports on holiday retail sales and data that showed manufacturing unexpectedly advanced last month.
Newmont Mining Corp., the world’s second-largest gold producer, slipped 2.3 percent as the precious metal’s price declined. Amazon.com Inc. fell 0.8 percent after the U.S. Supreme Court rejected an appeal from the company in a case over Internet sales taxes. EBay Inc. climbed 3.7 percent as a report showed online spending on Black Friday rose to a record.
Continue Reading
|
By Ben Rooney: CNNMoney
|
Bulls look for new market highs in December
It was an incredible November for stocks in what's been an amazing year for the market. Will the rally continue in December?
The Dow Jones industrial average and the Nasdaq both ended November with a gain of about 3.5%. The S&P 500 advanced almost 3%. The Dow and S&P 500 are near record highs, while the Nasdaq rose above 4,000 last week for the first time in 13 years.
So far this year, the S&P 500 has soared nearly 27% in the latest phase of a bull market that started in March, 2009.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
